| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/04/2011 | US20110189240 Microencapsulated compositions for endoluminal tissue engineering |
| 08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189152 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| 08/04/2011 | US20110189149 New Uses of Lactic Acid Bacteria and Bifidobacteria |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189092 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/04/2011 | CA2788326A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | CA2788078A1 Compositions and methods for prevention and treatment of pulmonary hypertension |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351744A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase |
| 08/03/2011 | EP2351743A1 Bicyclic compound |
| 08/03/2011 | EP2351573A1 Neuregulin in the treatment of heart diseases |
| 08/03/2011 | EP2351569A1 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| 08/03/2011 | EP2351568A2 Uses of dpp-iv inhibitors |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351483A1 Prevention and treatment of blood coagulation-related diseases |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350024A2 Improved process for the preparation of endothelin receptor antagonists |
| 08/03/2011 | EP2350021A1 Bridged tetrahydronaphthalene derivatives |
| 08/03/2011 | EP2350019A1 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 08/03/2011 | EP2349997A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives |
| 08/03/2011 | EP2349996A1 1-phenylpyrrole compounds |
| 08/03/2011 | EP2349979A2 Tetrahydronaphthalene compounds |
| 08/03/2011 | EP2349454A1 Facilitation of resuscitation from cardiac arrest by erythropoietin |
| 08/03/2011 | EP2349321A1 Annexin and its use to treat inflammatory disorders |
| 08/03/2011 | EP2349304A1 Uses of curculigo latifolia (c. latifolia) extracts |
| 08/03/2011 | EP2349302A1 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds |
| 08/03/2011 | EP2349300A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 08/03/2011 | EP2349299A2 Chamomilla extract for the treatment of hypertension |
| 08/03/2011 | EP2349284A1 Methods and compositions for treatment of acute heart failure |
| 08/03/2011 | EP2349281A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
| 08/03/2011 | EP2349266A1 Sulfonamide containing compounds and uses thereof |
| 08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 08/03/2011 | EP2349250A1 Fatty acids for use as a medicament |
| 08/03/2011 | EP2349249A2 Synergistic composition for recovery and reduction of mild ischemic damage |
| 08/03/2011 | EP2349247A1 Chewing gum containing low dose amounts of water soluble vitamins |
| 08/03/2011 | EP2349236A2 Compositions and methods for treating or preventing hypoxic or ischemic injury |
| 08/03/2011 | EP2349205A2 Chewable gelled emulsions |
| 08/03/2011 | EP2222293B1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
| 08/03/2011 | EP1996542B1 Aliskiren nitrate salt |
| 08/03/2011 | EP1976502B1 Small molecule inhibitors of pdz interactions |
| 08/03/2011 | EP1843754B1 New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance |
| 08/03/2011 | EP1620132B1 Biological pacemaker |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1839931B Medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143939A Solid states of aliskiren free base |
| 08/03/2011 | CN102143757A Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling |
| 08/03/2011 | CN102143745A Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 08/03/2011 | CN102143743A Reducing cholesterol levels with combined use of querceting and statin |
| 08/03/2011 | CN102140126A Rotundic acid derivative and synthesis method thereof as well as application of rotundic acid derivative in preparing medicament for preventing and curing cardiovascular disease |
| 08/03/2011 | CN102140079A Novel yunaconitine and preparation method thereof as well as pharmaceutical composition based on compound as active ingredient and application of novel yunaconitine |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139110A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 08/03/2011 | CN102139109A Quality-stable preparation composition of angiotensin converting enzyme inhibitor |
| 08/03/2011 | CN102139095A Method for applying neuregulin to prevent, treat or delay cardiac ischemia reperfusion injuries, and composition for preventing, treating or delaying cardiac ischemia reperfusion injuries |
| 08/03/2011 | CN102139076A Traditional Chinese medicine for treating diabetic foot |
| 08/03/2011 | CN102139075A Traditional Chinese medicine for treating diabetic acral necrosis |
| 08/03/2011 | CN102139066A Chinese medicinalal soft capsule |
| 08/03/2011 | CN102139065A Capsule prepared from Chinese herbal medicines for treating cardiovascular and cerebrovascular diseases |
| 08/03/2011 | CN102139054A Traditional Chinese medicine for treating diabetic retinopathy |
| 08/03/2011 | CN102139044A Traditional Chinese medicine for treating diabetic coronary heart disease |
| 08/03/2011 | CN102139043A Traditional Chinese medicine for treating diabetic retinopathy |
| 08/03/2011 | CN102139026A Nasal spray for treating apoplexy and preparation method thereof |
| 08/03/2011 | CN102139025A Chinese medicinal preparation for treating coronary disease and preparation method thereof |
| 08/03/2011 | CN102139023A Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method |
| 08/03/2011 | CN102139005A Medicine for treating cardiovascular and cerebrovascular diseases |
| 08/03/2011 | CN102138974A Traditional Chinese medicine for treating diabetic cardiopathy |
| 08/03/2011 | CN102138970A Method for preparing compound salvia tablet |
| 08/03/2011 | CN102138968A Soft capsule containing natto and gingko |
| 08/03/2011 | CN102138967A Application of dracocephalum moldavica L. general flavone in preparing medicament for preventing and treating cerebrovascular disease |
| 08/03/2011 | CN102138960A Novel extraction process of dalbergiae oil through super (sub) critical carbon dioxide |
| 08/03/2011 | CN102138953A Application of chorispora bungeana or extract thereof in preparation of medicaments for preventing and treating cardiovascular and cerebrovascular diseases |
| 08/03/2011 | CN102138948A Medicament for treating hyperlipidemia and coronary sclerosis and preparation method thereof |
| 08/03/2011 | CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves |
| 08/03/2011 | CN102138944A Method for preparing ginkgo biloba extract dispersible tablets |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138921A Application of phthalimide derivatives to preparation of anti-angiogenesis medicaments |
| 08/03/2011 | CN102138920A Medicinal composition containing candesartan cilexetil and hydrochlorothiazide and preparation method thereof |
| 08/03/2011 | CN102138918A Application of kaempferol in the preparation of medicines for preventing and/or treating cardiovascular diseases |
| 08/03/2011 | CN102138912A Nifedipine osmotic pump controlled release tablet and preparation method thereof |
| 08/03/2011 | CN102138906A Clonidine hydrochloride sustained release micropill preparation |
| 08/03/2011 | CN102138901A Nasal spray or aerosol containing Fasudil |
| 08/03/2011 | CN102138899A Olmesartan liposome solid preparation |
| 08/03/2011 | CN102138894A Stable large-capacity fasudil hydrochloride injection |
| 08/03/2011 | CN102138892A Choline alfoscerate injection preparation as well as preparation method and detection method thereof |
| 08/03/2011 | CN102138888A Alprostadil lipid nanosphere gel and preparation method thereof |
| 08/03/2011 | CN101837047B Method for preparing concentrated Yinhuang oral liquid |